Denileukin diftitox for chemotherapy-resistant chronic lymphocytic leukemia

被引：0
|
作者：
不详
机构：
来源：
CLINICAL LYMPHOMA | 2003年 / 4卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：146 / 147
页数：2
相关论文
共 50 条
  • [21] Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease
    Shaughnessy, PJ
    Bachier, C
    Grimley, M
    Freytes, CO
    Callander, NS
    Essell, YH
    Flomenberg, N
    Selby, G
    Lemaistre, CE
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (03) : 188 - 193
  • [22] Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia
    Wendtner, Clemens-Martin
    Gregor, Michael
    LEUKEMIA & LYMPHOMA, 2018, 59 (02) : 300 - 310
  • [23] COMBINATION CHEMOTHERAPY AND STAGING IN CHRONIC LYMPHOCYTIC-LEUKEMIA
    SCOUROS, MA
    MURPHY, SG
    ANDERSON, MD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 115 - 115
  • [24] Targeting Control of Cell Cycle Enhances the Activity of Conventional Chemotherapy in Chemotherapy-Resistant Acute Myeloid Leukemia
    Ling, Victoria Y.
    Jacquelin, Sebastien
    Straube, Jasmin
    Haldar, Rohit
    Janardhanan, Yashaswini
    Cooper, Leanne T.
    Bruedigam, Claudia
    Cooper, Emily
    Godfrey, William
    Tey, Siok-Keen
    Bullinger, Lars
    Herold, Marco J.
    Baell, Jonathan
    Bywater, Megan
    Lane, Steven W.
    BLOOD, 2021, 138
  • [25] Chemotherapy-free treatment of chronic lymphocytic leukemia?
    Wendtner, C. -M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (41) : 2104 - 2106
  • [26] TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA WITH COP CHEMOTHERAPY
    LIEPMAN, M
    VOTAW, ML
    CANCER, 1978, 41 (05) : 1664 - 1669
  • [27] What Is the Role of Chemotherapy in Patients With Chronic Lymphocytic Leukemia?
    Cheson, Bruce D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (11): : 723 - 727
  • [28] Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?
    Øystein Bruserud
    Karl Johan Tronstad
    Emmet McCormack
    Bjørn Tore Gjertsen
    Cancer Immunology, Immunotherapy, 2006, 55 : 221 - 228
  • [29] The shrinking role of chemotherapy in the treatment of chronic lymphocytic leukemia
    Jacobs, Ryan W.
    Awan, Farrukh T.
    Leslie, Lori A.
    Usmani, Saad Z.
    Ghosh, Nilanjan
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (12) : 1177 - 1187
  • [30] RXR-selective retinoid, bexarotene (Targretin) upregulates IL2R expression and enhances sensitivity of B-chronic lymphocytic leukemia (CLL) cells to denileukin diftitox (ONTAK).
    Gorgun, G
    Foss, F
    BLOOD, 2001, 98 (11) : 150A - 150A
12345